90780-53-3

Basic information

• Product Name: 4,7,10,14,16,19-Docosahexaenoicacid, 13-hydroxy-, (4Z,7Z,10Z,14E,16Z,19Z)-
• Synonyms: 4,7,10,14,16,19-Docosahexaenoicacid, 13-hydroxy-, (E,Z,Z,Z,Z,Z)-
• CAS NO: 90780-53-3
• Molecular Formula: C22H32 O3
• Molecular Weight: 344.48768
• Mol File: 90780-53-3.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 511.2±50.0 °C(Predicted)
• Appearance: /
• Density: 0.995±0.06 g/cm3(Predicted)
• PKA: 4.58±0.10(Predicted)
• CAS DataBase Reference: 4,7,10,14,16,19-Docosahexaenoicacid, 13-hydroxy-, (4Z,7Z,10Z,14E,16Z,19Z)-(CAS DataBase Reference)
• NIST Chemistry Reference: 4,7,10,14,16,19-Docosahexaenoicacid, 13-hydroxy-, (4Z,7Z,10Z,14E,16Z,19Z)-(90780-53-3)
• EPA Substance Registry System: 4,7,10,14,16,19-Docosahexaenoicacid, 13-hydroxy-, (4Z,7Z,10Z,14E,16Z,19Z)-(90780-53-3)

Safety Data

• Hazardous Substances Data: 90780-53-3(Hazardous Substances Data)

Upstream product

• 6217-54-5 docosahexaenoic acid 

Relevant articles and documents

OXYLIPINS FROM LONG CHAIN POLYUNSATURATED FATTY ACIDS AND METHODS OF MAKING AND USING THE SAME

Disclosed are novel oxylipins, referred to herein as docosanoids, that are derived from C22 polyunsaturated fatty acids, and method of making and using such oxylipins. Also disclosed is the use of docosapentaenoic acid (C22:5n-6) (DPAn-6), docosapentaenoic acid (C22:5n-3) (DPAn-3), and docosatetraenoic acid (DTAn-6: C22:4n-6) as substrates for the production of novel oxylipins, and to the oxylipins produced thereby. Also disclosed is the use of DPAn-6, DPAn-3, DTAn-6, and/or the oxylipins derived therefrom, and/or novel docosanoids derived from the structures of C22 fatty acids, in therapeutic and nutritional or cosmetic applications, and particularly as anti-inflammatory or anti-neurodegenerative compounds. The invention also relates to novel ways of producing long chain polyunsaturated acid (LCPUFA)-rich oils and compositions that contain enhanced and effective amounts of LCPUFA-derived oxylipins, and particularly, docosanoids.